SPAC Alchemy Investments Announces Definitive Business Combination with Litigation Finance Firm Cartiga, Valuing Combined Entity at $582M Equity

summarizeSummary

Alchemy Investments Acquisition Corp 1 announced a definitive business combination with Cartiga, LLC, a litigation finance company, valuing the combined entity at approximately $582 million in equity, with Cartiga shareholders owning 93%.

check_boxKey Events

• Definitive Business Combination Announced

  Alchemy Investments Acquisition Corp 1 (SPAC) has entered into a definitive business combination agreement with Cartiga, LLC, a litigation finance company.

• Investor Presentation Filed

  An investor presentation detailing the proposed merger and Cartiga's business model, which focuses on legal assets with predictable cash flows, was filed.

• Combined Entity Valuation

  The pro forma equity value of the combined company is estimated at $582.1 million, with a pro forma enterprise value of $633.8 million.

• Ownership Structure Post-Merger

  Cartiga shareholders are expected to own 93% of the combined entity, with ALCY public shareholders holding 1% and ALCY Sponsor & Affiliates 6%.

auto_awesomeAnalysis

This 425 filing, accompanying an 8-K, announces the proposed business combination between the SPAC, Alchemy Investments Acquisition Corp 1, and Cartiga, LLC. This is a pivotal event for the SPAC, as it outlines its future operations and valuation. The investor presentation details Cartiga's business in litigation finance, highlighting its strong track record and growth potential. The pro forma valuation of the combined entity at approximately $582 million in equity value represents a significant increase from Alchemy's current market capitalization, indicating a transformational transaction. However, the ownership structure, with Cartiga shareholders holding 93% of the combined company, implies substantial dilution for existing Alchemy public shareholders. The $40 million PIPE financing, structured as a convertible security with a conversion price of $7.00, is below the current stock price, which could lead to further dilution upon conversion. Investors should evaluate the long-term growth prospects of Cartiga against the dilutive impact of the transaction.